¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Golgi's mixed method"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • analytical method
    ºÐ¼®¹ý
  • bioassay method
    »ý¹°ÇÐÀû°ËÁ¤¹ý
  • bisecting method
    À̵îºÐ¸é¹ý
  • Black method
    ºí·¢¹æ¹ý
  • blind method
    ´«°¡¸²¹ý
  • bolus-tracking method
    µ¢¾î¸®ÃßÀû¹æ¹ý
  • brine flotation method
    ½Ä¿°¼öºÎÀ¯¹ý
  • candle jar method
    ÃкҺ´¹è¾ç¹ý
  • capillary tube method
    ¸ð¼¼½ÃÇè°ü¹ý
  • column diffusion method
    ±âµÕÈ®»ê¹æ¹ý
  • capture-recapture method
    Æ÷ȹÀçÆ÷ȹ¹ý
  • comparative method
    ºñ±³¹ý
  • compensation method
    º¸»ó¹ý
  • convergent method
    ¼ö·ÅÁ¶»ç¹ý
  • cough plate method
    ±âħÆòÆÇ¹ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • allochromatic method
    º¯»ö¹ý
  • alternate paired case method
    ±³´ë´ë¸³È¯ÀÚ¿ä¹ý
  • analytical method
    ºÐ¼®¹ý
  • ascending method
    »ó½Â¹ý
  • aspirative irrigation method
    ÈíÀμ¼Ã´¹ý
  • auscultatory method
    ûÁø¹ý
  • bioassay method
    »ý¹°ÇÐÀû°ËÁ¤¹ý
  • bisecting method
    À̵îºÐ¸é¹ý
  • black method
    ºí·¢¹æ¹ý
  • bolus-tracking method
    µ¢¾î¸®ÃßÀû¹æ¹ý
  • brine flotation method
    ½Ä¿°¼öºÎÀ¯¹ý
  • candle jar method
    ÃкҺ´¹è¾ç¹ý
  • capillary tube method
    ¸ð¼¼½ÃÇè°ü¹ý
  • cava pocket method
    ´ëÁ¤¸ÆÆ÷ÄϹý
  • chain termination method
    ¿¬¼âÁ¾·á¹ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • Lyman s method
    ¶óÀ̸¸¹ý.
  • Maitlands culture method
    ¸¶ÀÌÆ®·£µå¹è¾ç¹ý
  • Mancini method
    ¸¸½Ã´Ï¹ý
  • Octoson scanning method
    ¿ÁÅä¼Õ ½ºÄµ¹ý (Ûö)
  • Proetz displacement method
    ÇÁ·ÚÃ÷ġȯ¹ý
  • Quellung method
    ÆØÃ¢¹ý(ø³óìÛö).
  • Quellung method
    ÆØÃ¢¹ý(ø³óìÛö).
  • Rothera method
    ·ÎÅ×¶ó¹ý
  • Schoenheimer-Sperry method
    ½¨ÇÏÀ̸Ó-½ºÆä¸® ¹æ¹ý
  • Shihabi-Bishop method
    ½ÃÇϺñ-ºñ¼ó ¹æ¹ý
  • Spinner method
    ½ºÇdzÊ(¹æ)¹ý
  • Tietz-Fiereck method
    ƼÂÅ-ÇÇ·º¹æ¹ý
  • Valsalva method
    ¹ß»ì¹Ù¹ý
  • Wintrobe hematocrit method
    À©Æ®·ÎºêÇ츶ÅäÅ©¸®Æ®¹ý
  • Zebra-stripe imaging method
    ¾ó·è¸» ¹«´Ì ¿µ»ó ¹æ¹ý
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • mixed decimal
    ´ë¼Ò¼ö(ËÀËÛËà).
  • mixed dental arch
    È¥ÇÕÄ¡¿­°æ.
  • mixed dentition
    È¥ÇÕÄ¡±º(¡­öÍÏØ).
  • mixed diet
    È¥(ÇÕ)½ÄÀÌ(¡­ãÝìÈ).
  • mixed echo
    È¥ÇÕ ¿¡ÄÚ, È¥ÇÕ ¸Þ¾Æ¸®
  • mixed echo
    È¥ÇÕ (ûèùê) ¿¡ÄÚ, È¥ÇÕ (ûèùê) ¸Þ¾Æ¸®
  • mixed episode
    È¥À缺»ðÈ­(ûèî¤àõߺü¥)
  • mixed feeding
    È¥ÇÕ¿µ¾ç(¡­ç½å×).
  • mixed filling
    È¥ÇÕÃæÀü(¡­õöîó).
  • mixed form
    È¥ÇÕÇü(ûèùêû¡).
  • mixed fraction
    ´ëºÐ¼ö(ÓáÝÂâ¦).
  • mixed fraction
    ´ëºÐ¼ö(ËÀËÓËà).
  • mixed function oxidase
    È¥ÇÕ±â´É¿Á½Ãµ¥À̽º.
  • mixed function oxidase
    º¹ÇÕ±â´É»êÈ­È¿¼Ò(ÜÜùêѦÒöß«ûùý£áÈ).
  • mixed gas
    È¥ÇÕ±âü(ûèùêѨô÷).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • Folch method
    ÆúÃ÷¹ý(Ûö)
  • Folin method
    Æú¸°¹ý(Ûö)
  • Folin-Wu method
    Æú¸°-¿ì¹ý(Ûö)
  • gaseous exposure method
    °³½º ³ëÃâ¹ý(ÖÚõóÛö)
  • Gilbert-Maxam method
    ±æ¹öÆ®-¸Æ»ï¹ý(Ûö)
  • gradient-flow method
    ±¸¹è(ÎþÛÕ)-È帧¹ý(Ûö)
  • heavy atom method
    Áß¿øÀÚ¹ý(ñìê«í­Ûö)
  • high-temperature-short-time method
    °í¿Â ´Ü½Ã°£¹ý(ÍÔè®Ó­ãÁÊàÛö)
  • isotope derivative method
    µ¿À§¿ø¼ÒÀ¯µµÃ¼¹ý(ÔÒêÈêªáÈë¯Óôô÷Ûö)
  • jump method
    ¶Ù±â ¹æ¹ý(Û°Ûö)
  • Kjeldahl method
    Ű¿¤´Þ¹ý(Ûö)
  • label triangulation method
    Ç¥Áö»ï°¢È­¹ý(øöò½ß²ÊÇûùÛö)
  • Lowry method
    ·Î¿ì¸®¹ý(Ûö)
  • low-temperature heat method
    Àú¿Â¿­¹ý(î¸è®æðÛö)
  • LTH method
    LTH¹ý(Ûö)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
CAM calf aortic microsome; cell adhesion molecule; cell-associating molecule; chorioallantoic membrane; ...
CPM central pontine myelinosis; chlorpheniramine maleate; continuous passive motion; critical path metho...
CPRAM controlled partial rebreathing anesthesia method
DBCL dilute blood clot lysis [method]
DEALE declining exponential approximation of life expectancy [method]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
PCR polimerase chain reaction method
SCAM substituted cysteine accessibility method
AMLR Autologous mixed lymphocyte reaction
EMC Essential Mixed Cryoglobulinemia
MMMT Malignant Mixed Mesodermal Tumor
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • discomfort with this imaging method
    ÃÔ¿µ½Ã ºÒÆí°¨
  • double investing method
    ÀÌÁß ¸Å¸ô¹ý
  • draining method
    ¹è³ó¹ý, È긮´Â ¹æ¹ý
    »óó, ±Ë¾ç, °øµ¿¿¡¼­ ¾×ü³ª ¹è¼³¹°À» ü°èÀûÀ¸·Î ¹èÃâ½ÃŰ´Â °Í.
  • dye dilution method
    »ö¼Ò Èñ¼®¹ý
  • electromyogram biofeedback method
    ±ÙÀüµµ ¹ÙÀÌ¿ÀÇǵå¹é¹ý
    ¹ÙÀÌ¿ÀÆÐµå¹éÀÇ ÁöÇ¥·Î ±ÙÀüµµ¸¦ »ç¿ëÇÏ´Â °ÍÀÌ°í ±Ù·Â Áõ°­ ÈÆ·Ã°ú ±Ù ÀÌ¿Ï ÈÆ·Ã°ú´Â ÀüÇô ¹Ý´ëÀÇ Ä¡·á¹ýÀ¸·Î ÇÔ²² ÀÌ¿ëµÈ´Ù. ±Ù·Â Áõ°­ ÈÆ·ÃÀ¸·Î¼­´Â ¸»ÃÊ½Å°æ ¸¶ºñ, ³úÁ¹Áß, ³ú¼º ¸¶ºñ µî¿¡ »ç¿ëµÇ°í ±ÙÀÌ¿Ï ÈÆ·ÃÀ¸·Î¼­´Â »ç°æ µî¿¡ »ç¿ëµÈ´Ù.
  • expansion method
    ÆØÃ¢ ¹æ¹ý
    ¸Å¸ôÀçÀÇ °æÈ­ ÆØÃ¢, °¡¿­ ÆØÃ¢À» ÀÌ¿ëÇϰųª ¸ðÇü Àç·áÀÇ °æÈ­ ÆØÃ¢À» ÀÌ¿ëÇÏ´Â ¹æ¹ýÀÌ´Ù.
  • fast gradient recalled echo method
    °í¼Ó °æ»ç ȸº¹ ¿¡ÄÚ ±â¹ý
  • flash method
    ¿ìÀ¯ ¼Òµ¶¹ý
    ¿ìÀ¯¸¦ 80¡É±îÁö ±Þ¼ÓÈ÷ °¡¿­ÇÑ ÈÄ¿¡ ±Þ¼ÓÈ÷ 5¡É·Î ³»¸®´Â ¸ê±Õ¹ý.
  • functional jaw orthopedic method
    ±â´ÉÀû ¾Ç±³Á¤¹ý
  • immunofluorescence method
    ¸é¿ª Çü±¤¹ý
    Ç×ü³ª Ç׿ø¿¡ Ç÷ç¿À·¹¼¼ÀÎÀ̳ª ·Î´Ù¹Î°ú °°Àº Çü±¤ »ö¼Ò¸¦ Ç¥ÁöÇÑ °ÍÀ» »ç¿ëÇÏ¿© ü¾×°ú Á¶Á÷ µî¿¡ Á¸ÀçÇÏ´Â Ç׿ø ¶Ç´Â Ç×ü¸¦ °ËÃâÇÏ´Â ¹æ¹ý. Ç×ü¸¦ Ç¥ÁöÇÏ´Â °æ¿ì¿¡´Â ´ë°³ Çü±¤ Ç×ü¹ýÀ̶ó°í ºÎ¸¥´Ù. Á÷Á¢¹ý°ú °£Á¢¹ýÀÇ 2°¡Áö ¹æ¹ýÀÌ Àִµ¥, Çü±¤ Ç×üÀÇ °æ¿ì¸¦ ¸»Çϸé Á÷Á¢¹ýÀº Á¶Á÷ ¼Ó¿¡ Á¸ÀçÇÏ´Â Ç׿ø¿¡ ´ëÇÏ¿© ƯÀÌÇÏ°Ô °áÇÕÇÏ´Â Çü±¤ Ç¥Áö Ç×ü¸¦ ¾ãÀº Á¶Á÷ ÀýÆí¿¡ ¹ÝÀÀ½Ã۰í, ±× ÀýÆíÀ» Àß ¾Ä¾î¼­ Çü±¤Çö¹Ì°æÀ¸·Î °üÂûÇϸé Á¶Á÷ ¼ÓÀÇ Ç׿ø°ú °áÇÕÇÑ Çü±¤ Ç×ü°¡ Çü±¤À» ¹ßÇϹǷΠ±× Ç׿øÀÇ Á¸À縦 ¾Ë ¼ö ÀÖ´Ù. °£Á¢¹ýÀº ¸ÕÀú Á¶Á÷ ÀýÆí ¼ÓÀÇ Ç׿ø°ú ÀÌ¿¡ ´ëÀÀÇÏ´Â ¹«Ç¥Áö Ç×ü¸¦ ¹ÝÀÀ½ÃŲ ÈÄ¿¡ ¾Ä°í, ¹«Ç¥Áö Ç×ü¿Í ƯÀÌÇÏ°Ô ¹ÝÀÀÇϴ ǥÁö Ç×ü¸¦ ¹ÝÀÀ½ÃÄѼ­ ¾ÄÀº ´ÙÀ½ Çü±¤Çö¹Ì°æÀ¸·Î °üÂûÇÏ¿© Ç׿øÀÇ Á¸À縦 °£Á¢ÀûÀ¸·Î °ËÃâÇÏ´Â ¹æ¹ýÀ¸·Î¼­ Á÷Á¢¹ý¿¡ ºñÇØ Çü±¤·®ÀÌ Áõ´ëÇϹǷΠ°ËÃâ¿¡ ¿ëÀÌÇÏ´Ù.
  • indirect method
    °£Á¢¹ý
    䵿ÇÑ Àλ󿡼­ Á¦ÀÛµÈ ¸ðÇü»ó¿¡¼­ Ä¡°ü ¼öº¹¹°À» Á¦ÀÛÇÏ´Â ¹æ¹ý.
  • indirect-direct method inlay
    Á÷Á¢ °£Á¢¹ý Àη¹ÀÌ
    Á÷Á¢¹ý°ú °£Á¢¹ýÀ» º´¿ëÇÏ¿© ¸¸µç Àη¹ÀÌ.
  • injection molding method
    »çÃâ ¼ºÇü¹ý
  • Kaiserling's method
    Ä«ÀÌÁ¦¸¦¸µ ÀúÀå¹ý
    Ç¥º»À» Æ÷¸£¸»¸° 40cc, ¹° 2,000cc, Áú»êÄ®·ý 30g, ÃÊ»ê Ä®·ý 60g,ÀÇ ¿ë¾×¿¡ 14Àϰ£ °íÁ¤ÇÑ´Ù. Ç¥º»ÀÇ »öÁ¶¸¦ Àç»ý½Ã۱â À§ÇÏ¿© 10-60ºÐ°£ 80% ¿¡Æ¿ ¾ËÄڿÿ¡ ´ã±Ù´Ù. º¸Á¸ ¾×¿¡´Â ±Û¸®¼¼¸° 500cc, 1% ¾Æºñ»ê 200cc, ¹° 2300cc, ÃÊ»ê Ä®·ý 250g, Ƽ¸ô 2.5g¸¦ È¥ÇÕÇÑ´Ù
  • label method
    øÆ÷ ¹æ¹ý
    µ¿ÀǾî=
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
mixed lymphocyte culture test Measure of histocompatibility at the hl-a locus. Peripheral blood lymphocytes from two individuals are mixed together in tissue culture for several days. Lymphocytes from incompatible individuals will stimulate each other to proliferate significantly (measured by tritiated thymidine uptake) whereas those from compatible individuals will not. In the one-way mlc test, the lymphocytes from one of the individuals are inactivated (usually by treatment with mitomycin c or radiation) thereby allowing only the untreated remaining population of cells to proliferate in response to foreign histocompatibility antigens.
(12 Dec 1998)
mixed lymphocyte reaction <haematology, immunology, investigation> Reaction of mitogenesis produced in T lymphocytes when allogeneic (i.e. Mixed) lymphocytes are brought together, provided they are mismatched in histocompatibility loci. Once used as a test for possible graft compatibility in human grafting. Now known that a negative reaction is a poor predictor of graft acceptance.
(18 Nov 1997)
mixed mesodermal tumour A sarcoma of the body of the uterus arising in older women, composed of more than one mesenchymal tissue, especially including striated muscle cells.
Synonym: malignant mixed mullerian tumour.
(05 Mar 2000)
mixed nerve <anatomy, nerve> A nerve containing both afferent and efferent fibres.
(05 Mar 2000)
mixed opioid agonist-antagonist <pharmacology> A compound that has an affinity for two or more types of opioid receptors and blocks opioid effects on one receptor type while producing opioid effects on a second receptor type.
(13 Nov 1997)
mixed paralysis Combined motor and sensory paralysis.
(05 Mar 2000)
mixed sleep apnoea <chest medicine> A form of sleep apnoea where there is exists a combination of obstructive and central sleep apnoea syndromes.
(13 Nov 1997)
mixed thrombus A laminated thrombus, the layers of different ages being of different colour or consistency.
Synonym: stratified thrombus.
(05 Mar 2000)
mixed tide <ecology, marine biology> Tidal cycle in which there are usually two high and two low tides during a day.
(13 Nov 1997)
mixed tumour A tumour composed of two or more varieties of tissue.
(05 Mar 2000)
mixed tumour, malignant A malignant tumour composed of more than one type of neoplastic tissue.
(12 Dec 1998)
mixed tumour, mesodermal A sarcoma of the body of the uterus arising in older women, composed of more than one mesenchymal tissue, especially including striated muscle cells. It is associated with previous pelvic radiation exposure in 20% of patients.
(12 Dec 1998)
mixed tumour, mullerian A tumour, basically a carcinoma with a single sarcoma such as leiomyosarcoma or angiosarcoma or multiple sarcomas of uterine origin. The role of oestrogen has been postulated as a possible aetiological factor in this tumour. (holland et al., cancer medicine, 3d ed, p1703)
(12 Dec 1998)
mixed tumour of salivary gland A tumour composed of salivary gland epithelium and fibrous tissue with mucoid or cartilaginous areas.
Synonym: pleomorphic adenoma.
(05 Mar 2000)
mixed tumour of skin <tumour> A benign tumour of sweat glands with a mucoid stroma showing cartilaginous metaplasia.
Synonym: mixed tumour of skin.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á